130 related articles for article (PubMed ID: 37810628)
1. Quantification of OATP1B1 endogenous metabolites coproporphyrin I and III in human urine.
Jang Y; Kang J; Hwang S; Chung JY; Cho JY
Transl Clin Pharmacol; 2023 Sep; 31(3):139-147. PubMed ID: 37810628
[TBL] [Abstract][Full Text] [Related]
2. Development of an LC-MS method to quantify coproporphyrin I and III as endogenous biomarkers for drug transporter-mediated drug-drug interactions.
Njumbe Ediage E; Dillen L; Vroman A; Diels L; Kunze A; Snoeys J; Verhaeghe T
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():80-89. PubMed ID: 29241088
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
Suzuki Y; Sasamoto Y; Yoshijima C; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
J Pharm Biomed Anal; 2020 May; 184():113202. PubMed ID: 32114159
[TBL] [Abstract][Full Text] [Related]
4. Utilization of OATP1B Biomarker Coproporphyrin-I to Guide Drug-Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry.
Kikuchi R; Chothe PP; Chu X; Huth F; Ishida K; Ishiguro N; Jiang R; Shen H; Stahl SH; Varma MVS; Willemin ME; Morse BL
Clin Pharmacol Ther; 2023 Dec; 114(6):1170-1183. PubMed ID: 37750401
[TBL] [Abstract][Full Text] [Related]
5. Substantially Increased Plasma Coproporphyrin-I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population.
Suzuki Y; Sasamoto Y; Koyama T; Yoshijima C; Nakatochi M; Kubo M; Momozawa Y; Uehara R; Ohno K
Clin Transl Sci; 2021 Jan; 14(1):382-388. PubMed ID: 32961019
[TBL] [Abstract][Full Text] [Related]
6. A fully automated and validated human plasma LC-MS/MS assay for endogenous OATP biomarkers coproporphyrin-I and coproporphyrin-III.
King-Ahmad A; Clemens S; Ramanathan R; Zhang Y; Raha N; Zhang Y; Holliman C; Rodrigues AD; Li F
Bioanalysis; 2018 May; 10(9):691-701. PubMed ID: 29747517
[TBL] [Abstract][Full Text] [Related]
7. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
[TBL] [Abstract][Full Text] [Related]
8. Relationship of hemoglobin level and plasma coproporphyrin-I concentrations as an endogenous probe for phenotyping OATP1B.
Suzuki Y; Sasamoto Y; Koyama T; Yoshijima C; Oda A; Nakatochi M; Kubo M; Momozawa Y; Uehara R; Ohno K
Clin Transl Sci; 2021 Jul; 14(4):1403-1411. PubMed ID: 33650309
[TBL] [Abstract][Full Text] [Related]
9. UHPLC-MS/MS bioanalysis of human plasma coproporphyrins as potential biomarkers for organic anion-transporting polypeptide-mediated drug interactions.
Kandoussi H; Zeng J; Shah K; Paterson P; Santockyte R; Kadiyala P; Shen H; Shipkova P; Langish R; Burrrell R; Easter J; Mariannino T; Marathe P; Lai Y; Zhang Y; Pillutla R
Bioanalysis; 2018 May; 10(9):633-644. PubMed ID: 29749254
[TBL] [Abstract][Full Text] [Related]
10. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
Bednarczyk D; Boiselle C
Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540
[TBL] [Abstract][Full Text] [Related]
11. A highly selective and sensitive LC-MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting peptide biomarkers.
Ramanathan R; King-Ahmad AJ; Holliman CL; Rodrigues AD
Bioanalysis; 2017 Nov; 9(22):1787-1806. PubMed ID: 28978230
[TBL] [Abstract][Full Text] [Related]
12. Quantitative prediction of OATP1B-mediated drug-drug interactions using endogenous biomarker coproporphyrin I.
Takubo H; Bessho K; Watari R; Shigemi R
Xenobiotica; 2022 Apr; 52(4):397-404. PubMed ID: 35638858
[TBL] [Abstract][Full Text] [Related]
13. Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition.
Lai Y; Mandlekar S; Shen H; Holenarsipur VK; Langish R; Rajanna P; Murugesan S; Gaud N; Selvam S; Date O; Cheng Y; Shipkova P; Dai J; Humphreys WG; Marathe P
J Pharmacol Exp Ther; 2016 Sep; 358(3):397-404. PubMed ID: 27317801
[TBL] [Abstract][Full Text] [Related]
14. Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study.
Kalluri HV; Kikuchi R; Coppola S; Schmidt J; Mohamed MF; Bow DAJ; Salem AH
Clin Transl Sci; 2021 Jan; 14(1):373-381. PubMed ID: 33048456
[TBL] [Abstract][Full Text] [Related]
15. Alteration in the Plasma Concentrations of Endogenous Organic Anion-Transporting Polypeptide 1B Biomarkers in Patients with Non-Small Cell Lung Cancer Treated with Paclitaxel.
Mori D; Ishida H; Mizuno T; Kusumoto S; Kondo Y; Izumi S; Nakata G; Nozaki Y; Maeda K; Sasaki Y; Fujita KI; Kusuhara H
Drug Metab Dispos; 2020 May; 48(5):387-394. PubMed ID: 32114508
[TBL] [Abstract][Full Text] [Related]
16. Further Evaluation of Coproporphyrins as Clinical Endogenous Markers for OATP1B.
Feng S; Bo Q; Coleman HA; Charoin JE; Zhu M; Xiao J; Jin Y
J Clin Pharmacol; 2021 Aug; 61(8):1027-1034. PubMed ID: 33460165
[TBL] [Abstract][Full Text] [Related]
17. Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition.
Shen H; Christopher L; Lai Y; Gong J; Kandoussi H; Garonzik S; Perera V; Garimella T; Humphreys WG
Drug Metab Dispos; 2018 Aug; 46(8):1075-1082. PubMed ID: 29777022
[TBL] [Abstract][Full Text] [Related]
18. Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin-I and blood concentration of cyclosporin A in real-world patients.
Watanabe T; Tanaka R; Suzuki Y; Sato H; Negami J; Yoshijima C; Oda A; Ono H; Tatsuta R; Ohno K; Itoh H
Br J Clin Pharmacol; 2023 May; 89(5):1672-1681. PubMed ID: 36517987
[TBL] [Abstract][Full Text] [Related]
19. Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression.
Zhang Y; Chen C; Chen SJ; Chen XQ; Shuster DJ; Puszczalo PD; Fancher RM; Yang Z; Sinz M; Shen H
J Pharmacol Exp Ther; 2020 Oct; 375(1):139-151. PubMed ID: 32719071
[TBL] [Abstract][Full Text] [Related]
20. Utility of Coproporphyrin-I Determination in First-in-Human Study for Early Evaluation of OATP1B Inhibitory Potential Based on Investigation of Ensitrelvir, an Oral SARS-CoV-2 3C-Like Protease Inhibitor.
Watari R; Sawada H; Hashimoto H; Kasai Y; Oka R; Shimizu R; Matsuzaki T
J Pharm Sci; 2024 Mar; 113(3):798-805. PubMed ID: 37742997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
